TxCell raises cash for first-in-man CAR-Treg cell therapy study
TxCell has raised €11m ($11.6m) through a share issue which it will use to fund first-in-man study of one of its cell therapy candidates.
Archives for February 24, 2017
LegoChem signs up Novimmune as latest ADC licensee
LegoChem Biosciences has teamed up with Novimmune to develop and test antibody drug conjugate (ADC) drug.